Experts in the field of clinical trials have emphasized the importance of keeping states informed about ongoing trials to ensure transparency and accountability. Clinical trials play a crucial role in the development of new treatments and drugs, but there have been instances where lack of communication with state authorities has led to ethical violations and safety concerns. It is essential for states to be aware of all clinical trials taking place within their jurisdiction to monitor the process and protect the rights of participants. By keeping states informed, researchers can also benefit from local knowledge and resources that can enhance the quality of the trials. Experts recommend establishing clear communication channels between researchers, regulatory bodies, and state governments to facilitate this exchange of information. This proactive approach can help prevent conflicts and ensure that clinical trials are conducted in compliance with all regulations and ethical standards. In India, where the pharmaceutical industry is rapidly growing, maintaining transparency and collaboration between stakeholders is crucial for the success of clinical trials. By involving states in the process from the beginning, researchers can build trust and credibility, ultimately leading to better healthcare outcomes for the population. It is hoped that by prioritizing communication and cooperation, the clinical trial landscape in India will continue to evolve in a positive direction, benefiting both researchers and the public.